4,473 Shares in Danaher Corporation (NYSE:DHR) Acquired by TLP Group LLC

TLP Group LLC bought a new stake in shares of Danaher Corporation (NYSE:DHR) during the first quarter, according to its most recent disclosure with the SEC. The firm bought 4,473 shares of the conglomerate’s stock, valued at approximately $383,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Parnassus Investments CA increased its position in Danaher Corporation by 15.3% in the first quarter. Parnassus Investments CA now owns 8,622,528 shares of the conglomerate’s stock valued at $712,738,000 after buying an additional 1,143,284 shares during the last quarter. Bank of New York Mellon Corp raised its stake in Danaher Corporation by 0.7% in the first quarter. Bank of New York Mellon Corp now owns 7,645,818 shares of the conglomerate’s stock valued at $653,946,000 after buying an additional 50,673 shares during the last quarter. Flossbach Von Storch AG raised its stake in Danaher Corporation by 6.2% in the first quarter. Flossbach Von Storch AG now owns 3,996,209 shares of the conglomerate’s stock valued at $341,796,000 after buying an additional 234,770 shares during the last quarter. First Manhattan Co. raised its stake in Danaher Corporation by 0.8% in the first quarter. First Manhattan Co. now owns 2,932,760 shares of the conglomerate’s stock valued at $229,899,000 after buying an additional 22,098 shares during the last quarter. Finally, Findlay Park Partners LLP raised its stake in Danaher Corporation by 28.1% in the first quarter. Findlay Park Partners LLP now owns 2,692,348 shares of the conglomerate’s stock valued at $230,277,000 after buying an additional 590,000 shares during the last quarter. 76.12% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Danaher Corporation (NYSE DHR) traded down 0.05% on Friday, reaching $80.87. 2,861,306 shares of the company were exchanged. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.01. The company has a market capitalization of $56.18 billion, a P/E ratio of 25.81 and a beta of 1.03. The stock has a 50 day moving average of $82.32 and a 200-day moving average of $84.22.

Danaher Corporation (NYSE:DHR) last issued its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. During the same period in the previous year, the business posted $0.90 earnings per share. The business’s revenue was up 6.3% compared to the same quarter last year. On average, analysts predict that Danaher Corporation will post $3.95 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.com-unik.info/2017/08/19/tlp-group-llc-invests-383000-in-danaher-corporation-nysedhr-updated-updated-updated.html.

Several equities research analysts have commented on DHR shares. Zacks Investment Research lowered shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Monday, June 19th. Deutsche Bank AG reaffirmed a “buy” rating and issued a $97.00 price target on shares of Danaher Corporation in a report on Wednesday, June 21st. BTIG Research reaffirmed a “buy” rating and issued a $92.00 price target on shares of Danaher Corporation in a report on Sunday, April 23rd. Wells Fargo & Company started coverage on shares of Danaher Corporation in a report on Thursday, July 13th. They issued a “market perform” rating and a $90.00 price target on the stock. Finally, BidaskClub lowered shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Saturday, July 8th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Danaher Corporation presently has a consensus rating of “Buy” and a consensus target price of $91.76.

In related news, insider William King sold 7,458 shares of the business’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $82.97, for a total transaction of $618,790.26. Following the sale, the insider now owns 18,245 shares of the company’s stock, valued at $1,513,787.65. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Angela S. Lalor sold 10,815 shares of the business’s stock in a transaction dated Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total transaction of $910,190.40. Following the sale, the senior vice president now directly owns 39,020 shares in the company, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 38,623 shares of company stock worth $3,206,426. Company insiders own 12.20% of the company’s stock.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

What are top analysts saying about Danaher Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Danaher Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit